1,306
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway

, , &
Pages 832-837 | Received 16 May 2014, Accepted 16 Jul 2014, Published online: 17 Sep 2014

References

  • Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002;50:873–6.
  • Osterlund A, Eden T, Olsson-Liljequist B, Haeggman S, Kahlmeter G. Swedish Study Group on Fusidic Acid- resistant Staphylococcus aureus. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002;34:729–34.
  • O’Neill AJ, Larsen AR, Henriksen AS, Chopra I. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 2004;48:3594–7.
  • O’Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid- resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007;45:1505–10.
  • Larsen AR, Skov RL, Jarlier V, Henriksen AS. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 2008;61:589–94.
  • Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands. J Antimicrob Chemother 2012;67:1176–80.
  • Rørtveit S, Skutlaberg DH, Langeland N, Rortveit G. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics. J Antimicrob Chemother 2011;66:1360–4.
  • Alsterholm M, Flytström I, Bergbrant IM, Faergemann J. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 2010;90:52–7.
  • Dalager-Pedersen M, Søgaard M, Schønheyder HC. Staphylococcus aureus skin and soft tissue infections in primary healthcare in Denmark: a 12-year population-based study. Eur J Clin Microbiol Infect Dis 2011;30: 951–6.
  • Rørtveit S, Rortveit G. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population. Br J Dermatol 2007;157:100–5.
  • Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteriafor bacterial strain typing. J Clin Microbiol 1995;33:2233–9.
  • Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald G, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003;41:5442–8.
  • Osterlund A, Kahlmeter G, Haeggmann S, Olsson- Liljequist B. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study. Scand J Infect Dis 2006;38:334–4.
  • NORM/NORM-VET 2012. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo 2013. ISSN:1502-2307 (print)/1890-9965. Available from: URL: http://www.vetinst.no/Publikasjoner/NORM-NORM-VET/NORM-NORM-VET-2012
  • Shallcross LJ, Petersen I, Rosenthal J, Johnson AM, Freemantle M, Hayward AC. Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010. Emerg Infect Dis 2013;19:1646–8.